WILMINGTON, Del., June 20, 2012 -- Butamax™ Advanced Biofuels, LLC, the leading
biobutanol technology company, commented today on the court’s decision to deny Butamax’s
motion for a preliminary injunction. Although requests for preliminary injunctions are often
denied, Butamax maintains that there are strong grounds for making this request and plans an
“The court’s decision is not a final determination of infringement or invalidity concerning the 188
and 889 patents as it is merely a determination that the extraordinary remedy of a preliminary
injunction is not available at this time. This is an early step in a long and complex litigation
process,” commented Paul Beckwith, Butamax CEO. “We remain highly confident in the
ultimate outcome of this case and our other cases against Gevo.”
Butamax’s request for the preliminary injunction was only based on a select number of claims of
Butamax’s ‘889 patent. At trial, Butamax’s case on all the claims of both the ‘188 and ‘889
patents will be heard. Full trial in this case is scheduled for April, 2013. Additionally, Butamax
has several other patents and patent applications it will seek to enforce as appropriate.
Butamax™ Advanced Biofuels, LLC was formed to develop and commercialize biobutanol as a
next generation renewable biofuel for the transport market. The company benefits from the
synergy of DuPont’s proven industrial biotechnology experience and BP’s global fuels market
knowledge. Butamax’s proprietary technology offers a cost-advantaged manufacturing process
for isobutanol with value from field to pump. For more information, visit www.butamax.com.
Butamax™ is a trademark of Butamax™ Advanced Biofuels, LLC.